CHEMED CORP Operating Income Loss

• CHEMED CORP showed a decrease of -7.7% in Operating Income Loss from 2024 to 2025.
• This data is from CHEMED CORP's annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2010: $34.45 million | Q2 2010: $33.86 million | Q3 2010: $36.76 million | Q1 2011: $30.55 million | Q2 2011: $35.84 million | Q3 2011: $41.31 million | Q1 2012: $34.98 million | Q2 2012: $39.53 million | Q3 2012: $35.97 million | Q1 2013: $38.85 million | Q2 2013: $25.89 million | Q3 2013: $29.21 million | Q1 2014: $36.65 million | Q2 2014: $41.52 million | Q3 2014: $40.21 million | Q1 2015: $40.57 million | Q2 2015: $44.60 million | Q3 2015: $50.13 million | Q1 2016: $44.39 million | Q2 2016: $38.36 million | Q3 2016: $42.87 million | Q1 2017: $41.45 million | Q2 2017: -$38.95 million | Q3 2017: $54.00 million | Q1 2018: $56.40 million | Q2 2018: $58.14 million | Q3 2018: $61.71 million | Q1 2019: $49.47 million | Q2 2019: $65.53 million | Q3 2019: $64.93 million | Q1 2020: $79.36 million | Q2 2020: $92.76 million | Q3 2020: $74.31 million | Q1 2021: $80.44 million | Q2 2021: $71.70 million | Q3 2021: $92.87 million | Q1 2022: $89.37 million | Q2 2022: $91.94 million | Q3 2022: $80.86 million | Q1 2023: $72.82 million | Q2 2023: $69.51 million | Q3 2023: $86.85 million | Q1 2024: $72.33 million | Q2 2024: $88.13 million | Q3 2024: $92.16 million | Q1 2025: $94.76 million | Q2 2025: $68.08 million | Q3 2025: $74.75 million.
• Over the full 18 years of available data (2008 to 2025), CHEMED CORP's Operating Income Loss has grown by 154.6%.
• Historical annual values: Fiscal year 2025: $338.25 million | Fiscal year 2024: $366.49 million | Fiscal year 2023: $340.57 million | Fiscal year 2022: $343.50 million | Fiscal year 2021: $343.04 million | Fiscal year 2020: $389.68 million | Fiscal year 2019: $257.38 million | Fiscal year 2018: $243.63 million | Fiscal year 2017: $113.04 million | Fiscal year 2016: $178.75 million | Fiscal year 2015: $184.46 million | Fiscal year 2014: $168.42 million | Fiscal year 2013: $133.39 million | Fiscal year 2012: $156.42 million | Fiscal year 2011: $153.73 million | Fiscal year 2010: $143.52 million | Fiscal year 2009: $126.35 million | Fiscal year 2008: $132.86 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026